Santyl (colleganase) for diabetic foot ulcers

NewsBot · Apr 12, 2014

Members do not see these Ads. Sign Up.
This clinical trial was just registered:
Santyl Applications to Diabetic Foot Ulcers

The current trial examines the potential benefits of continuous 12 week treatment with Santyl, measured in terms of wound bed appearance. The visual appearance of granulation tissue will be recorded at each visit for the purpose of examining the relationship between wound bed appearance and progress towards healing. In support of this longer treatment regimen with Santyl, a recent animal study found that application of Santyl for 12 weeks was safe and well tolerated. Therefore, the present study is designed to test the hypothesis that daily treatment of diabetic foot ulcers (DFU) with Santyl for up to 12 weeks will result in more rapid development of granulation tissue than DFU treated with supportive care.
Click to expand...

Santyl = colleganase

Admin2 · Apr 12, 2014

Related Threads:
EpiFix for diabetic foot ulcers
Lipo-PGE for diabetic foot ulcers
CollaRx for Diabetic Foot Ulcers
DermaPure for diabetic foot ulcers
MatriStem for diabetic foot ulcers
Grafix for Treatment of Diabetic Foot Ulcers
Resveratrol for diabetic foot ulcers

NewsBot · Oct 21, 2015

Another clinical trial registered on it:
Use of Santyl in Diabetic Foot Ulcers

This study is designed to test the hypothesis that daily treatment of diabetic foot ulcers with an enzymatic debriding agent, SANTYL, for up to 6 weeks will result in more rapid decrease in ulcer area than diabetic foot ulcers treated with a topical treatment containing silver. After meeting study criteria, participants will be randomly assigned to apply Santyl or a topical treatment containing silver to their to foot ulcer for up to 6 weeks. At the end of 6 weeks, participants will be followed for an additional 4 weeks to examine the outcome of the study treatment.
Click to expand...

NewsBot The Admin that posts the news.

Admin2 Administrator Staff Member

NewsBot The Admin that posts the news.

Share This Page